Display options
Cite
Hofford RS, Bond PN, Chow JJ, et al. Presence of a social peer enhances acquisition of remifentanil self-administration in male rats. Drug Alcohol Depend. 2020;213:108125doi: 10.1016/j.drugalcdep.2020.108125.
Hofford, R. S., Bond, P. N., Chow, J. J., & Bardo, M. T. (2020). Presence of a social peer enhances acquisition of remifentanil self-administration in male rats. Drug and alcohol dependence, 213108125. https://doi.org/10.1016/j.drugalcdep.2020.108125
Hofford, Rebecca S, et al. "Presence of a social peer enhances acquisition of remifentanil self-administration in male rats." Drug and alcohol dependence vol. 213 (2020): 108125. doi: https://doi.org/10.1016/j.drugalcdep.2020.108125
Hofford RS, Bond PN, Chow JJ, Bardo MT. Presence of a social peer enhances acquisition of remifentanil self-administration in male rats. Drug Alcohol Depend. 2020 Jun 18;213:108125. doi: 10.1016/j.drugalcdep.2020.108125. Epub 2020 Jun 18. PMID: 32590212; PMCID: PMC7371539.
Copy Download .nbib Format: NLM
Share it on

Drug Alcohol Depend. 2020 Jun 18;213:108125. doi: 10.1016/j.drugalcdep.2020.108125. Epub 2020 Jun 18.

Presence of a social peer enhances acquisition of remifentanil self-administration in male rats.

Drug and alcohol dependence

Rebecca S Hofford, Paige N Bond, Jonathan J Chow, Michael T Bardo

Affiliations

  1. University of Kentucky, Department of Psychology, Lexington, KY, USA. Electronic address: [email protected].
  2. University of Kentucky, Department of Psychology, Lexington, KY, USA.

PMID: 32590212 PMCID: PMC7371539 DOI: 10.1016/j.drugalcdep.2020.108125

Abstract

BACKGROUND: Social peers influence human drug use at every stage of addiction. Using a dual-compartment apparatus that allows for limited social contact, recent work has shown that cocaine self-administration is enhanced when two rats are trained to self-administer at the same time compared to rats trained alone or trained in the presence of a saline self-administration control peer. The current study measured social influence on self-administration of the short-acting opioid remifentanil using a dual-compartment operant conditioning chamber.

METHODS: Adult male rats were placed in one of five groups: (1) REMI-REMI group, in which both rats self-administered remifentanil; (2) REMI-SAL group, in which rats self-administered remifentanil in the presence of a peer that self-administered saline; (3) SAL-REMI group, in which rats self-administered saline in the presence of a peer that self-administered remifentanil; and (4) REMI ALONE and (5) SAL ALONE groups, in which rats administered their respective drugs alone (no peer). Self-administration was measured using a 2-lever procedure during acquisition, maintenance, increasing fixed-ratio, and dose-response phases.

RESULTS: The presence of a social peer enhanced drug intake during acquisition, regardless of the drug exposure of their peer. Additionally, active lever position significantly affected remifentanil intake during acquisition and maintenance, with the greatest influence occurring when the active lever was close to the peer.

CONCLUSION: The presence of a social peer in the drug-taking context potentiates remifentanil self-administration, regardless of the peer's drug access. Future studies utilizing the dual-compartment apparatus will help elucidate the neural mechanisms underlying social influence on opioid abuse.

Copyright © 2020 Elsevier B.V. All rights reserved.

Keywords: Opioid; Peer; Remifentanil; Self-administration; Social

Conflict of interest statement

Declaration of Competing Interest No conflict declared.

References

  1. J Neurosci. 2011 Apr 27;31(17):6362-70 - PubMed
  2. Pharmacol Biochem Behav. 2009 Dec;94(2):285-95 - PubMed
  3. Nat Protoc. 2020 Apr;15(4):1542-1559 - PubMed
  4. Behav Processes. 2006 Nov 1;73(3):360-6 - PubMed
  5. J Subst Use. 2011 Apr;16(2):150-160 - PubMed
  6. Neuropharmacology. 2019 Nov 15;159:107332 - PubMed
  7. Psychopharmacology (Berl). 2007 Jun;192(3):397-406 - PubMed
  8. Psychopharmacology (Berl). 1995 Jan;117(2):225-31 - PubMed
  9. Psychopharmacology (Berl). 1993;110(1-2):5-12 - PubMed
  10. J Pharmacol Exp Ther. 1988 Dec;247(3):815-23 - PubMed
  11. J Neurosci Methods. 2014 Oct 30;236:11-8 - PubMed
  12. Psychopharmacology (Berl). 2018 Dec;235(12):3391-3400 - PubMed
  13. Behav Pharmacol. 2013 Apr;24(2):114-23 - PubMed
  14. Psychopharmacology (Berl). 2014 Apr;231(8):1503-15 - PubMed
  15. Nat Rev Neurosci. 2011 Oct 05;12(11):685-700 - PubMed
  16. Nat Neurosci. 2018 Nov;21(11):1520-1529 - PubMed
  17. J Pharm Sci. 1997 Nov;86(11):1278-82 - PubMed
  18. Psychol Rev. 2008 Jan;115(1):186-98 - PubMed
  19. J Exp Anal Behav. 1962 Oct;5:529-30 - PubMed
  20. Biol Psychiatry. 2010 Jan 1;67(1):28-35 - PubMed
  21. J Sch Health. 2015 Feb;85(2):82-9 - PubMed
  22. Psychopharmacology (Berl). 2008 Jun;198(3):395-404 - PubMed
  23. Anesthesiology. 2014 Nov;121(5):1037-44 - PubMed
  24. J Comp Physiol Psychol. 1955 Apr;48(2):73-6 - PubMed
  25. Psychopharmacology (Berl). 2012 Nov;224(1):81-90 - PubMed
  26. Psychopharmacology (Berl). 2017 Dec;234(23-24):3499-3506 - PubMed
  27. Psychopharmacology (Berl). 2000 May;150(1):61-6 - PubMed
  28. Psychopharmacology (Berl). 2016 Sep;233(17):3201-10 - PubMed
  29. Alcohol Clin Exp Res. 2009 Feb;33(2):273-82 - PubMed
  30. Dev Psychobiol. 2004 Nov;45(3):153-62 - PubMed
  31. Soc Cogn Affect Neurosci. 2016 Dec;11(12):1902-1909 - PubMed
  32. Psychopharmacology (Berl). 2001 May;155(3):278-84 - PubMed
  33. Exp Clin Psychopharmacol. 2011 Dec;19(6):409-19 - PubMed
  34. Exp Clin Psychopharmacol. 2016 Aug;24(4):285-96 - PubMed

Publication Types

Grant support